VA (Venoarterial) ECMO (Extracorporeal Membrane Oxygenation) 

VA (Venoarterial) ECMO (Extracorporeal Membrane Oxygenation) can also be used in the post-heart transplant setting, although it is not as common as in the pre-transplant setting. In general, VA ECMO is used for post-heart transplant patients with acute cardiac or hemodynamic compromise due to any number of reasons. These reasons include, but are not limited to, primary graft dysfunction, acute transplant rejection, and other post-transplant complications among others. Below are the considerations regarding indications, benefits, challenges, and prognosis associated with the use of VA ECMO following heart transplantation.

Reasons for VA ECMO Use After Heart Transplant

Primary Graft Dysfunction (PGD):

PGD refers to the condition whereby the donor heart fails to function adequately following transplantation. This is often the most common indication for the use of VA ECMO following heart transplant due to the fact that PGD usually presents within 24-48 hours of the surgery. Causes of PGD following heart transplant include ischemic injury of the organ, reperfusion injury, and donor-recipient incompatibility.

VA ECMO enables the donor heart to receive the support it needs to resume normal functions.

Acute Rejection:

Acute transplant rejection can take place within days and weeks following heart transplant and is a major concern following the procedure. Patients that experience acute transplant rejection can require VA ECMO due to the fact that the transplant heart can fail due to the attack of the recipient’s immune system on this foreign organ. In this scenario, VA ECMO is useful in allowing the immunosuppressive therapy to take effect.

Infections:

Following heart transplant, patients are very susceptible to infections, and sepsis is among the possible complications following the surgery. Sepsis can lead to multiple organ dysfunction syndrome (MODS) and hemodynamic instability that can necessitate the use of VA ECMO as a life-supporting measure.

Severe Arrhythmias:

These can be a complication following heart transplant or a side effect of acute transplant rejection or infections. Severe arrhythmias can be life-threatening and require the use of VA ECMO until they resolve.

Pulmonary Complications:

Following heart surgery, patients usually present with pulmonary edema or other pulmonary difficulties that can lead to hemodynamic instability. In such circumstances, VA ECMO can be used as a life-supporting measure.

Bridging to Recovery or Other Interventions:

VA ECMO can also be used following heart transplant to bridge patients to recovery, for instance, recovery of the transplanted heart following acute transplant rejection.

VA ECMO Mechanism Following Heart Transplant

The mode of action of VA ECMO is similar to that of VA ECMO that is used in the pre-transplant settings. It works by bypassing the heart by diverting blood from the veins to an oxygenator that oxygenates the blood before being pumped back to the arteries. This way, VA ECMO provides circulatory and respiratory support, which allows the transplanted heart to recover and stabilize.

Benefits of VA ECMO Following Heart Transplant

Provision of Immediate Circulatory and Respiratory Support:

VA ECMO provides immediate circulatory and respiratory support to patients following heart transplant who present with acute cardiac and/or respiratory distress. This benefit of VA ECMO post-heart transplant is very valuable in cases such as acute transplant rejection, primary graft dysfunction, and infections. The circulatory and respiratory support offered by VA ECMO in these cases facilitates the provision of appropriate treatment to patients.

VA ECMO Can Be a Bridge to Recovery:

In many of the acute conditions discussed above that require VA ECMO post-heart transplant, targeted treatment can improve the patients’ conditions. For example, acute transplant rejection can be managed by immunosuppressive therapy. Similarly, infections can also be treated with antibiotics and other appropriate treatment modalities. In such cases, VA ECMO can be a bridge to recovery for patients with acute cardiac and respiratory distress following heart transplant.

Support During Multiple Organ Failure:

In cases of multiple organ failure, VA ECMO can also offer support to the other organs, thus enabling them to recover.

VA ECMO Can Serve as a Bridge to Additional Clinical Interventions:

In cases of transplant rejection and primary graft dysfunction where VA ECMO is used to stabilize the patient, the mechanical circulatory support offered by VA ECMO can serve as a bridge to additional clinical interventions necessary to treat these conditions.

Challenges and Risks Associated with VA ECMO After Heart Transplant

Bleeding:

A significant risk that is associated with VA ECMO following heart transplant is bleeding, either at the cannulation site or elsewhere, which often necessitates medical intervention. Following heart transplant, patients are also very prone to infections, which can result in sepsis, leading to multiple organ dysfunction syndrome (MODS). In addition to this, patients on VA ECMO are also more likely to develop nosocomial infections that may be very detrimental to their wellbeing.

Vascular Injury:

During cannulation of the arteries and veins, vascular injury can also occur, resulting in ischemia and subsequent bleeding, especially in patients that have undergone VA ECMO for extended periods of time.

Organ Dysfunction:

VA ECMO can also result in multiple organ dysfunction, for example, kidney or liver damage following heart transplant, resulting in prolonged ICU stay.

Device-related Complications:

Device-related complications such as malfunction of the VA ECMO machine can also arise following VA ECMO post-heart transplant, which can be very detrimental to the patient.

Delayed Graft Function:

Following the use of VA ECMO following heart transplant in conditions such as primary graft dysfunction, it is possible to have poor response to VA ECMO. This results in a poor prognosis for the transplanted heart.

Prognosis Following VA ECMO in Post-Transplant Patients

Short-Term Prognosis:

In most cases, the prognosis of patients that require VA ECMO following heart transplant is generally good, especially in the short term. This is mainly because VA ECMO usually acts as a bridge to effective treatment for most of the conditions it is used for. The short-term prognosis following the use of VA ECMO for transplant rejection, for example, is largely determined by the response of the patient to immunosuppressive therapy. Similarly, the prognosis for VA ECMO use in conditions such as infections is also dependent on the response to antibiotics and other appropriate treatment.

Long-Term Prognosis:

The long-term prognosis for patients that undergo VA ECMO following heart transplant largely depends on the indication for VA ECMO as well as the response to the interventions that VA ECMO is a bridge to.

Graft Prognosis:

The prognosis of the transplanted heart following VA ECMO largely depends on whether adequate recovery of the graft occurs. This is more likely to be the case when VA ECMO is used for transplant rejection rather than primary graft dysfunction. In addition, the prognosis of the heart graft largely depends on how quickly the patient recovers following VA ECMO and whether they require additional intervention or not. If VA ECMO fails to support the transplanted heart and the patient is taken off VA ECMO, additional intervention may be needed. If additional intervention is not required once VA ECMO is taken off, a good prognosis can be expected. On the other hand, if intervention is needed, the prognosis largely depends on what intervention is required, for example, re-transplantation in the case of transplant rejection.

Conclusion

VA ECMO can be used to offer circulatory and respiratory support to post-heart transplant patients with acute cardiac and/or respiratory distress. VA ECMO is a very valuable intervention for these patients; however, it is also associated with various risks and challenges. Following heart transplant, VA ECMO is usually a bridge to effective treatment; prognosis following its use is generally good in the short term, but it largely depends on the indication for VA ECMO and the response to the interventions.